Suppr超能文献

一种新的人类CC趋化因子受体基因的分子克隆与功能表达

Molecular cloning and functional expression of a new human CC-chemokine receptor gene.

作者信息

Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M

机构信息

IRIBHN, Université libre de Bruxelles, Beligum.

出版信息

Biochemistry. 1996 Mar 19;35(11):3362-7. doi: 10.1021/bi952950g.

Abstract

The cloning of several receptors activated by either CC or CXC chemokines and belonging to the G protein-coupled family of receptors has been reported recently. In the present work, we describe the cloning of a human gene, named ChemR13, encoding a new CC-chemokine receptor. The gene encodes a protein of 352 amino acids with a calculated molecular mass of 40 600 Da and displaying a single potential site for N-linked glycosylation. Using a set of overlapping lambda clones, the genomic organisation of the locus was investigated, demonstrating that the ChemR13 gene is physically linked, and in the same orientation, as the CC-CKR2 gene that encodes a receptor for the monocyte chemoattractant protein-1 (MCP-1). A distance of 17.5 kb separates the two coding regions, which share 75% identity in nucleic acid and amino acid sequences. Human ChemR13 was functionally expressed in a stably transfected CHO-K1 cell line. Physiological responses to chemokines were monitored using a microphysiometer. Macrophage inflammatory protein 1 alpha (MIP-1 alpha) was the most potent agonist. MIP-1 beta and RANTES were also active at physiological concentrations. The other CC-chemokines, MCP-1, MCP-2 and MCP-3, as well as CXC-chemokines (IL-8, GRO alpha) had no effect. ChemR13 receptor transcripts were detected by Northern blotting in the promyeloblastic cell line KG-1A, suggesting a potential role in the control of granulocytic lineage proliferation or differentiation. ChemR13 is thus a new member of the growing family of chemokine receptors that mediate the recruitment of cells involved in immune and inflammatory processes. Being the fifth functionally identified receptor in his class, this new CC-chemokine receptor (CC-CKR) is tentatively designated CC-CKR5.

摘要

最近有报道称,已克隆出几种由CC或CXC趋化因子激活且属于G蛋白偶联受体家族的受体。在本研究中,我们描述了一个名为ChemR13的人类基因的克隆,该基因编码一种新的CC趋化因子受体。该基因编码一个由352个氨基酸组成的蛋白质,计算分子量为40600 Da,具有一个潜在的N-连接糖基化位点。利用一组重叠的λ克隆,研究了该基因座的基因组结构,结果表明ChemR13基因与编码单核细胞趋化蛋白-1(MCP-1)受体的CC-CKR2基因在物理上相连且方向相同。两个编码区相距17.5 kb,其核酸和氨基酸序列具有75%的同一性。人ChemR13在稳定转染的CHO-K1细胞系中实现了功能表达。使用微生理仪监测对趋化因子的生理反应。巨噬细胞炎性蛋白1α(MIP-1α)是最有效的激动剂。MIP-1β和RANTES在生理浓度下也有活性。其他CC趋化因子,MCP-1、MCP-2和MCP-3,以及CXC趋化因子(IL-8、GROα)均无作用。通过Northern印迹法在早幼粒细胞系KG-1A中检测到ChemR13受体转录本,提示其在粒细胞系增殖或分化控制中可能发挥作用。因此,ChemR13是介导参与免疫和炎症过程的细胞募集的趋化因子受体不断增加的家族中的一个新成员。作为该类中第五个被功能鉴定的受体,这个新的CC趋化因子受体(CC-CKR)被暂定为CC-CKR5。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验